A new study led by Massachusetts General Hospital (MGH) investigators finds that radiation therapy may increase the uptake of therapeutic nanoparticles by glioblastomas, raising the possibility of using both growth-factor-targeted and immune-system-based therapies against the deadly brain tumor. The team describes how pretreatment with low-dose radiation increased delivery to tumors of nanoparticles carrying small interfering RNA (siRNA) molecules and significantly improved survival in a mouse model of glioblastoma.
“We found that radiation therapy primes brain tumors for enhanced uptake of nanotherapeutics, allowing us to develop a targeted nanoparticle to deliver siRNAs for both immune checkpoint and targeted therapy against the most aggressive type of brain tumor,” says Bakhos Tannous, PhD, of the Neuro-Oncology Division in the MGH Department of Neurology, senior author of the report published in ACS Nano. “A brief burst of radiation was able to increase uptake of the nanoparticle up to five-fold, enhancing the effects of targeted therapy, activating the immune response at the tumor site and prolonging survival.”
While up to 60 percent of glioblastomas express the EGFR growth factor, a molecule used in targeted therapies against several types of cancer, EGFR-targeted therapies have had little success against the brain tumors. Similarly immunotherapies directed against immune checkpoints such as CTLA-4 and PD-L1 have promising results against many cancers but not yet against glioblastoma. Some studies have suggested an association between EGFR activation and increased PD-L1 expression, raising the possibility that targeted both could increase the antitumor effects.
In order to deliver siRNAs targeting both EGFR and PD-L1 to brain tumors, the researchers developed a solid lipid nanoparticle guided by a tumor-targeting peptide called iRGD, which binds to a molecule present on blood vessels lining the tumor, allowing it to penetrate both the blood-brain and blood-tumor barriers. Factors such as the small size and positive charge of this nanoparticle allow it to penetrate the blood-brain barrier; and like other solid lipid nanoparticles, its low cost, stability, biodegradability and ease of manufacture make it an attractive option, explains Gulsah Erel-Akba, PhD, of MGH Neuro-Oncology and Izmir Katip Celebi University in Turkey, the first author of the study.
Image Credit: massgeneral.org
News This Week
Frank Boehm: Publication of our new paper “Human Brain/Cloud Interface” in Frontiers in Neuroscience
Contributors: Nuno R. B. Martins, Amara Angelica, Yuriy Svidinenko, Frank J. Boehm, Ioan Opris, Mikhail A. Lebedev, Melanie Swan, Steven A. Garan, Jeffrey V. Rosenfeld, Tad Hogg, Robert A. Freitas Jr. et al Excerpt [...]
Abstract The progressive growth in nanotechnology approaches to diagnostics and therapeutics, especially for cancer, necessitates training physicians in nanoethics. This article explains why it is critical for medical education to include instruction in [...]
The rise of Candida auris embodies a serious and growing public health threat: drug-resistant germs. In May, an elderly man was admitted to the Brooklyn branch of Mount Sinai Hospital for abdominal surgery. A [...]
In a collaboration between the U.S. Department of Energy's Ames Laboratory and Northeastern University, scientists have developed a model for predicting the shape of metal nanocrystals or "islands" sandwiched between or below two-dimensional (2D) [...]
Should we be prepared to change the population composition of a species in order to wipe out a disease that is a terrible burden to mankind? During a well-attended working breakfast organised by the [...]
A new study led by Massachusetts General Hospital (MGH) investigators finds that radiation therapy may increase the uptake of therapeutic nanoparticles by glioblastomas, raising the possibility of using both growth-factor-targeted and immune-system-based therapies against [...]
Taking a cue from biological cells, researchers from MIT, Columbia University, and elsewhere have developed computationally simple robots that connect in large groups to move around, transport objects, and complete other tasks. This [...]
Nearly a third of physicians will be sued at least once in their careers — most commonly for an error in diagnosis. Medical errors are also the third-leading cause of death in the United [...]
Inventors and scientists have been continuously working towards reducing the size of technological components. Room-sized computers to laptops that are slimmer than a pane of glass? It’s done. Huge bulky telephones to smartphones that [...]
You have witnessed a variety of nano-devices that were designed for tasks including delivering medicines within the body. All of them used to move in a variety of ways. However, the latest nano-device is [...]
Netra Rajesh is an undergraduate Engineering Science student specializing in Biomedical Systems Engineering. She is currently on her Professional Experience Year (PEY) at the Massachusetts Institute of Technology where her research lies at the [...]